Search results
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024...
Benzinga· 4 days ago"The latest data from our preclinical study demonstrates KRRO-110 has the potential to restore AAT protein levels well beyond the minimum threshold considered to have an impact for patients, ...
McClellan: 3 books about St. Louis, perfect for summer reading
St. Louis Post-Dispatch· 6 days agoSummer is almost here and although St. Louis is far from the beach, it’s time to think about beach...
Neurocrine Biosciences Announces Publication of Phase 3 KINECT®-4 Post Hoc Analysis Demonstrating...
The Mammoth Times· 3 days agoNeurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of data from a post hoc analysis of the Phase 3 KINECT®-4 study of INGREZZA® (valbenazine) capsules in the Journal ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 24 hours agoZentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental ...
‘Culture-changing’: History of radio is thriving in this fascinating, hidden Silicon Valley museum
Roanoke Times· 6 days agoWalk into a nondescript building in Alameda, California — which happens to have once been the first...
AP Sports Digest
The Fredericksburg Free Lance-Star· 2 days agoAn up-to-the minute listing of all stories planned, including games and events, is available in Coverage Plan on AP Newsroom, https://newsroom.ap.org/coverageplan. You can also find a link to ...
Nevada delegation leaves mark on FAA bill
Elko Daily Free Press· 4 days agoThe Federal Aviation Administration reauthorization bill isn’t the sexiest piece of legislation, but it’s essential — it governs U.S. air travel, and...
AP Sports Digest
The Fredericksburg Free Lance-Star· 5 days agoAn up-to-the minute listing of all stories planned, including games and events, is available in Coverage Plan on AP Newsroom, https://newsroom.ap.org/coverageplan. You can also find a link to ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 24 hours agoMultiple refractory PD1 failure patients experienced prolonged progression free survival (10 months ongoing); confirmed responses observed in patients receiving evalstotug High doses of evalstotug as either a monotherapy or in combination with
Foundation Fighting Blindness Awards Inaugural Grants in PRPH2 and Associated Retinal Diseases...
WKRN Nashville· 2 days agoThe Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, has announced the recipients of the first awards in the PRPH2 and ...
